Enterococcus hirae is a Gram-positive coccus that was isolated from the rabbit intestinal.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
CAT | Size | Price | Quantity | |
---|---|---|---|---|
LBST-109FG |
|
Product Information | |
---|---|
Product Overview | Enterococcus hirae is a Gram-positive coccus that was isolated from the rabbit intestinal. |
Target | Enterococcus |
Genus | Enterococcus |
Strain Designation | RS9 |
Application | Study and research |
Type Strain | No |
Culture Medium | MRS |
Culture Conditions | 30°C; Aerobiotic |
Source | The rabbit intestinal |
Characteristics | It can use gluconate, L-arabinose, honey disaccharide, sucrose, rhamnose, mannitol, D-raffinose, xylose, sorbitol. Gram-positive, rod-shaped, blastless, round colony, catalase negative, facultative anaerobic, it can grow at 15°C and 45°C. |
Risk Group | 1 |
Product Format | Freeze-dried |
Packaging | Ampoule tube |
Storage | -80°C |
Shelf Life | 6 years |
Target Introduction | |
---|---|
Introduction | Enterococcus are lactic acid bacteria; LAB comprising both pathogenic and commensal microorganisms ubiquitous in environment even as gut symbionts. They are extensively studied as potential candidate probiotics. Several number of Enterococcus strains have been reported to produce antimicrobial compounds including bacteriocins. Bacteriocin production have be applied to preservation of a wide range of food products and is now being considered as a probiotic trait. Besides, bacteriocins are considered as promising alternative to fight emerging antimicrobial resistance. Enterococcus probiotics can be used in treatment and/or prevention of certain human and animal diseases such as alleviation of irritable bowel syndrome symptoms and antibiotic-induced diarrhea and prevention of different functional and chronic intestinal diseases. Moreover, some Enterococcus exhibit anticarcinogenic, hypocholesterolemic, as well as immune regulation effects. |
Alternative Names | Enterococcus hirae; RS9 |
Enterococcus hirae; RS9 should be stored at -80°C with cryoprotectants such as glycerol or trehalose to maintain viability. For short-term storage, refrigeration at 4°C on agar plates is suitable. Regular viability testing is recommended to ensure the culture remains viable.
Enterococcus hirae; RS9 can be freeze-dried and incorporated into capsules, tablets, or powdered formulations. It is essential to maintain viability during processing by using cryoprotectants like trehalose or glycerol. Stability studies should be conducted to ensure the strain remains active throughout the product's shelf life.
Techniques such as metagenomic sequencing, transcriptomics, and metabolomics are used to study the interactions between Enterococcus hirae; RS9 and the gut microbiota. These methods provide insights into how RS9 modulates the microbiome and its potential health benefits.
Safety considerations include ensuring that Enterococcus hirae; RS9 is non-pathogenic and free from virulence factors. Comprehensive genomic analysis and in vitro assays are conducted to confirm its safety profile before use in human studies.
The anti-inflammatory properties of Enterococcus hirae; RS9 can be evaluated using cell culture models, such as co-culturing with human intestinal epithelial cells or macrophages. Measurement of cytokine production and gene expression profiles provides insights into its immunomodulatory effects.
Click the button below to contact us or submit your feedback about this product.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2024 Creative Biolabs. All Rights Reserved.